Aktis Oncology Pursues $200 Million IPO On Promising Early Stage Studies

Aktis Oncology, Inc. targets $200M IPO to advance radiopharmaceuticals for solid tumors. Click for more on the upcoming AKTS ...
Pregnancy Boss

Roborock Saros 10R Review: Pros, Cons & Why It’s the Best Robot Vacuum (2026)

Compare top robot vacuum and mop combos with pricing, features, and expert analysis. Find the best deal today!